The Sertoli cell is the primary target for FSH action in the mammalian testis. These cells contain the majority of testicular plasma membrane receptors for this hormone. Receptor occupancy is directly correlated with a stimulation of adenylyl cyclase and a decrease in the activity ofa cytoplasmic Ca ++ -sensitive cAMP phosphodiesterase. Regulation ofthese two enzymes allows increased intracellular accumulation of cAMP, activation of cAMP-dependent protein kinase and phosphorylation of a variety of protein substrates. All of these events occur within the first 30 min following exposure of isolated Sertoli cells to FSH.
Introduction
The effects of toxic agents on the testis can be evaluated only by understanding the basic biological events which contribute to the normal functions within the testis. The Sertoli cell, to a large degree, dictates the development and maintenance of spermatogenesis within the testis. The Sertoli cell is regulated by both a steroid hormone, testosterone, and a peptide hormone, follicle stimulating hormone (FSH). Spermatogenesis is probably mediated by the action of these two hormones on Sertoli cells. By understanding the basic mechanisms by which hormones regulate the Sertoli cell and by identifying specific proteins which are themselves regulated by hormones we can begin to evaluate mechanisms by which toxic agents might be affecting spermatogenesis. Several recent reviews concern the hormonal regulation of spermatogenesis *Department of Cell Biology, Baylor College of Medicine, Houston, Texas 77030.
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and the mechanism of action of FSH (1) (2) (3) . In this article we will review three areas of FSH action: (a) The temporal sequence of events following addition of FSH to Sertoli cells in culture; (b) The stimulation of the synthesis of protein kinase inhibitor in the Sertoli cell; and (c) The hormonal regulation of androgen binding protein in Sertoli cells.
Mechanism of FSH Action
A proposed sequence of events for FSH action in the Sertoli cell is presented in Figure 1 . FSH binds to specific receptors on the membranes of Sertoli cells (4) (5) (6) When Sertoli cells were cultured for 2-3 days in completely defined medium, it was found that the continued presence of FSH resulted in a 5-to 7-fold greater level of PKI activity than cells cultured for the same period of time in the absence of hormone (14) . On the other hand, when cells were first cultured for 1 or 2 days without hormone, PKI activity declined. Subsequent exposure to FSH initiated a significant 3-to 4-fold stimulation in PKI activity (13) .
The ability of FSH to maintain PKI activity in Sertoli cells (from 16-day old rats) was found to be dependent on the concentration of FSH (Fig. 2) . Maximal PKI activity was observed in cultures containing 500 ng FSH/ml; half-maximal levels were achieved with as little as 80 ng FSH/ml (14) .
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The hormone specificity of the stimulation of Sertoli cell PKI was next examined. Cells from 16-day old animals were cultured for two days without hormone, then for 24 hr in the presence of FSH (500 ng/ml), LH (500 ng/ml), testosterone (1 x 106 M), or dibutryl cAMP (1 x 10-4 M). Of the hormones tested, only FSH induced a significant increase in PKI activity; it was also found that dibutyryl cAMP could mimic the effect of FSH (14) .
These results demonstrate that protein kinase inhibitor in the Sertoli cell is regulated by FSH in vitro. These data corroborate previous results obtained in vivo (12) (17, 18) , Sertoli cell-enriched rat testes (19) , isolated seminiferous tubules (20) , and Sertoli cells maintained in primary culture (21, 22 (24) .
Testosterone will maintain spermatogenesis in the absence of FSH (25) This has been demonstrated both acutely (28) and chronically (29) . However, the acute stimulation appears to result from 3tabilization of the protein in the presence of ligand (30) , whereas chronic treatment is more closely correlated with production of ABP. Chronic treatment of hypophysectomized rats with testosterone has demonstrated that this steroid will maintain normal levels of ABP in the apparent absence of FSH (31) .
When testosterone is administered together with FSH in vivo an augmentation of the ABP response above that found with FSH alone is observed (17) . This increased binding activity might be due to a synergism between testosterone and FSH. However, the increased binding may also have been due to the stabilizing influence of testosterone. In order to test these two possibilities, rats were injected for 4 days with either testosterone propionate, 8 FSH or a combination of the two hormones (23) . In rats treated with highly purified FSH for 4 days, no difference was found between these and the testosterone-treated rats. However, if the FSH treated testes were homogenized in the presence of stabilizing factors, a fourfold increase in binding activity was observed and no further change was seen in rats treated with FSH and testosterone propionate in vivo. These results demonstrated that testosterone, whether injected in vivo or included in the homogenization buffer, results in stabilization of any ABP present-in the testis. Thus, the apparent synergism between testosterone and FSH is due to the stabilizing influence of the steroid on ABP binding activity. However, this does not rule out possible direct effects of testosterone in vivo on ABP production which were described previously.
There has been much confusion over which hormone, FSH or testosterone, regulates androgen binding protein. This has been complicated by a number of factors. These include the age of the animal, the length of time following hypophysectomy before hormone administration, and the dose of hormone. ABP secretion in immature rats less than three weeks of age, i.e., before lumen formation and secretion begins, has an absolute requirement for FSH (32) . This cannot be replaced by testosterone. Even when secretion begins at about 16 days, administration of testosterone with FSH results in the abolishment of ABP secretion into the epididymis. This inhibitory effect of testosterone is not observed in rats 21 days or older. After 21 days of age, administration of testosterone propionate in large doses for 10 days will maintain levels of ABP similar to noninjected controls even though both FSH and LH are suppressed (33) . Furthermore, FSH administration to older rats results in increased ABP binding activity in a dose-dependent manner (23) .
Previous results suggested that changes in microfilament distribution could alter Sertoli cell shape and that cyclic AMP or low external calcium concentration (EGTA) could affect microfilaments in Sertoli cells (8) . We then measured ABP secretion by isolated cells to see if EGTA would affect secretion. As shown in Table 1 , EGTA caused rapid release of ABP, and cytochalasin B interfered with the EGTA effect. The results suggested involvement of microfilaments in the process of secretion of ABP.
The hormonal regulation of ABP secretion has been studied in vitro with testicular minces (34) , explants (35) and Sertoli cells grown in culture (2, 21, 22, 36) . However, these studies have not been as informative as initially hoped in that the specificity Environmental Health Perspectives (37) and therefore should be able to examine this question by measuring incorporation of labeled amino acids into the protein.
Studies of the effects of toxic agents on the testis can be meaningful only by understanding the basic biological mechanisms involved in regulating spermatogenesis. We have elucidated some basic mechanisms by which hormones regulate the Sertoli cell. By using specific endpoint determinants of hormone action, such as protein kinase inhibitor and androgen binding protein, we can begin to examine the effects of toxic agents on spermatogenesis.
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